MemorialCare Innovation Fund

Welldoc Data Shows Patient Engagement Increases 2.5 Times When Clinician and Xealth Involved | PR Newswire | 9/17/2019

SEATTLE and COLUMBIA, Md. , Sept. 17, Welldoc, a leader in digital health, today announced activation results for Welldoc’s award-winning BlueStar digital health product for managing diabetes can be four times higher when sent direct to the patient from their care team. This distribution was made possible through Xealth , the platform for connecting digital health, which integrated the BlueStar solution into the EHR workflow, simplifying the process of connecting patients …

How conversations with frontline hospital staff keep Xealth from becoming another ‘tone-deaf’ startup: 4 Qs with COO Aaron Sheedy | Becker’s Hospital Review | 9/10/2019

Aaron Sheedy is COO at Xealth, a Seattle-based digital health startup that makes it easier for health systems to integrate digital care vendors into their EHR platforms, from which clinicians can prescribe and monitor those vendors’ content, apps, devices and other services. Xealth spun out of Renton, Wash.-based Providence St. Joseph Health in 2017. The startup closed its $14 million Series A financing round in June of this …

Follow MemorialCare Innovation Fund:    

Health systems have invested millions in these 5 startups since February | Becker’s Hospital Review | 7/30/2019

… Alphabet’s GV and Verily Life Sciences. The company’s artificial intelligence multiomics platform analyzes blood samples for early stage cancer biomarkers. In June, Charlotte, N.C.-based Atrium Health, Cleveland Clinic and Long Beach, Calif.-based MemorialCare Innovation Fund invested $3 million in Xealth to complete its $14 million round of Series A financing. The Seattle-based startup, a spinoff from Providence St. Joseph Health, also received funding from UPMC, Froedtert and …

Term Sheet — Monday, June 24 | Fortune | 6/24/2019

Elisabeth Fall By Polina Marinova 8:34 AM EDT THE VC WHO’S SEEN IT ALL BEFORE Jeff Jordan has stayed largely behind the scenes even though he invested early in what are now some of the hottest companies in tech. On behalf of Andreessen Horowitz, Jordan backed home-­sharing giant Airbnb, grocery delivery company Instacart, and the hobbyist site ­Pinterest. The firm’s bet on Pinterest alone, one of Jordan’s first after …

Term Sheet – Monday, June 24 | Yahoo News | 6/24/2019

Term Sheet – Monday, June 24” data-reactid=”17” Term Sheet – Monday, June 24 More THE VC WHO’S SEEN IT ALL BEFORE Jeff Jordan has stayed largely behind the scenes even though he invested early in what are now some of the hottest companies in tech. On behalf of Andreessen Horowitz, Jordan backed home-­sharing giant Airbnb, grocery delivery company Instacart, and the hobbyist site ­Pinterest. The firm’s bet on Pinterest …

The Secrets of the Venture Capitalist Who’s Seen It All: Term Sheet | Fortune | 6/24/2019

THE VC WHO’S SEEN IT ALL BEFORE Jeff Jordan has stayed largely behind the scenes even though he invested early in what are now some of the hottest companies in tech. On behalf of Andreessen Horowitz, Jordan backed home-­sharing giant Airbnb, grocery delivery company Instacart, and the hobbyist site ­Pinterest. The firm’s bet on Pinterest alone, one of Jordan’s first after joining the firm in 2011, is worth $1 …

Atrium Health, Cleveland Clinic join latest funding round for startup Xealth | FierceHealthcare | 6/21/2019

by Heather Landi Jun 21, 2019 10:22am Xealth is a growing player in the “digital supply chain” that makes it possible for healthcare providers to prescribe and monitor digital therapies. (Rostislav_Sedlacek) Digital health startup Xealth has raised an additional $3 million in a series A financing round and has attracted new investment from major health systems Atrium Health, Cleveland Clinic and the MemorialCare Innovation Fund. The health systems join …

Xealth Raises $14M In Series A | 6/21/2019

Print Digital health startup Xealth has announced that it has raised an additional $3 million in its Series A financing, bringing the total amount raised in this funding round to $14 million. New investors Atrium Health, Cleveland Clinic and MemorialCare Innovation Fund joined McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network as participants in the …

Providence spinout Xealth ends $14M Series A funding round | The Business Journals | 6/20/2019

… had brought in $11 million, three additional investors have added to the pool. North Carolina-based not-for-profit hospital network Atrium Health, Ohio-based medical center Cleveland Clinic and health care investment fund MemorialCare Innovation Fund joined Xealth’s eight other investors. Xealth aims to set the bar for how doctors and clinicians interact with patients, CEO Mike McSherry said. “We digitally facilitate care in a way that’s not been …

Atrium, Cleveland Clinic, MemorialCare join digital health startup Xealth’s Series A | Becker’s Hospital Review | 6/20/2019

Atrium, Cleveland Clinic, MemorialCare join digital health startup Xealth’s Series A Andrea Park - Print Email Seattle-based digital health startup Xealth announced the close of its $14 million Series A financing round on June 20, following a $3 million infusion from Charlotte, N.C.-based Atrium Health, Cleveland Clinic and Long Beach, Calif.-based MemorialCare Innovation Fund. Previously announced health system investors in the round include University of Pittsburgh Medical Center …

Seattle startup Xealth secures $3M from Atrium Health, Cleveland Clinic and MemorialCare - MedCity News | 6/20/2019

Health IT , Hospitals , Startups Seattle startup Xealth secures $3M from Atrium Health, Cleveland Clinic and MemorialCare The Seattle-based company, which spun out of Providence St. Joseph Health, has a platform that allows clinicians to prescribe and monitor digital health tools from their EHR workflows. Post a comment / at 2:00 PM Shares 0 Xealth , a startup with a platform that lets clinicians prescribe and monitor digital health tools from their …

Cleveland Clinic, Atrium Health MemorialCare add $3M to Xealth’s Series A | MobiHealthNews | 6/20/2019

Search Cleveland Clinic, Atrium Health MemorialCare add $3M to Xealth’s Series A All three health systems will also start using the digital health app and device prescription platform. June 20, 2019 Share Providence St. Joseph health spinout Xealth, which aims to create a prescribing infrastructure for digital health apps, has raised $3 million in new funding, an add-on that brings its previously announced Series A up to $14 million …

Xealth adds Atrium Health, Cleveland Clinic and MemorialCare to close $14m Series A | PR Newswire | 6/20/2019

SEATTLE , June 20, Xealth, the leading platform for connecting digital health, today announced that it has secured an additional $3 million in its Series A financing, bringing the amount raised in this round to $14 million total. New investors Atrium Health, Cleveland Clinic and MemorialCare Innovation Fund join McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health …

Xealth Secures Additional $3M in Series A Funding | 6/20/2019

By FinSMEs Xealth , a Seattle, WA-based platform for connecting digital health, secured an additional $3m in its Series A financing, bringing the amount raised in this round to $14m total. New investors Atrium Health, Cleveland Clinic and MemorialCare Innovation Fund join McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network. The company intends to use …

Digital Prescribing Platform Xealth Raises Additional $3M to Close $14M Series A Round | HIT Consultant | 6/20/2019

… Seattle-based digital prescribing platform has raised an additional $3 million in its Series A financing, bringing the amount raised in this round to $14 million total. New investors Atrium Health, Cleveland Clinic and MemorialCare Innovation Fund join McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network. Investments from this round will be used to advance …

Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe Major Surgeries for Glaucoma Patients | PR Newswire | 5/2/2019

IRVINE, Calif. , May 2, Ivantis, Inc., developer of the novel Hydrus® Microstent , a micro-invasive glaucoma surgical (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, announced today that the 3 Year Results from the HORIZON pivotal study. The 2 year results, which were the foundation of FDA approval, were presented in November 2017 , and were recently published in the leading journal Ophthalmology. The 2 year effectiveness …

Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal | PR Newswire | 4/23/2019

IRVINE, Calif. , April 23, Ivantis Inc ., developer of the Hydrus ® Microstent, announced today that the 12-month results of the COMPARE study for minimally invasive glaucoma surgery (MIGS) were accepted into the journal Ophthalmology. COMPARE is the first prospective, multicenter, randomized trial comparing two MIGS devices, the Hydrus Microstent versus two Glaukos iStent ® Trabecular Micro-bypass stents, for the treatment of open-angle glaucoma in a standalone procedure. The trial …

Ivantis FDA Clinical Trial of the Hydrus® Microstent for Minimally Invasive Glaucoma Surgery (MIGS) Meets Endpoints, Exceeds Outcomes of Past MIGS Trials | PR Newswire | 11/13/2017

Ivantis FDA Clinical Trial of the Hydrus® Microstent for Minimally Invasive Glaucoma Surgery (MIGS) Meets Endpoints, Exceeds Outcomes of Past MIGS Trials News provided by 09:05 ET Share this article IRVINE, Calif. , Nov. Ivantis Inc. , developer of the novel Hydrus® Microstent , a micro-invasive glaucoma surgical (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, announced today that the HORIZON pivotal study has met both the two …

Digital Health

Welldoc Data Shows Patient Engagement Increases 2.5 Times When Clinician and Xealth Involved | PR Newswire | 9/17/2019

SEATTLE and COLUMBIA, Md. , Sept. 17, Welldoc, a leader in digital health, today announced activation results for Welldoc’s award-winning BlueStar digital health product for managing diabetes can be four times higher when sent direct … PSJH) in 2017, and investors include Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network …

How conversations with frontline hospital staff keep Xealth from becoming another ‘tone-deaf’ startup: 4 Qs with COO Aaron Sheedy | Becker’s Hospital Review | 9/10/2019

Aaron Sheedy is COO at Xealth, a Seattle-based digital health startup that makes it easier for health systems to integrate digital care vendors into their EHR platforms, from which clinicians can prescribe and monitor … year, with investors including Providence Ventures, Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, University of Pittsburgh Medical Center and Froedtert & the Medical College of Wisconsin network. In an interview with Becker’s , Mr. Sheedy described Xealth’s …

Digital Health Solutions

Atrium Health, Cleveland Clinic join latest funding round for startup Xealth | FierceHealthcare | 6/21/2019

… a series A financing round and has attracted new investment from major health systems Atrium Health, Cleveland Clinic and the MemorialCare Innovation Fund. The health systems join existing investors McKesson Ventures, Novartis, Philips, ResMed, Threshold … McSherry said, noting that Xealth’s platform has more than 30 digital health solutions. Over a million patient interactions are being prescribed and monitored by health systems through the platform, he said. The company will be …

Providence spinout Xealth ends $14M Series A funding round | The Business Journals | 6/20/2019

… Carolina-based not-for-profit hospital network Atrium Health, Ohio-based medical center Cleveland Clinic and health care investment fund MemorialCare Innovation Fund joined Xealth’s eight other investors. Xealth aims to set the bar for … platform. “By enabling our care teams to prescribe and monitor digital health solutions directly from within their clinical workflow, Xealth is the de facto standard for bridging the digital divide between our clinicians’ workflows and …

Digital Health Content

Atrium Health, Cleveland Clinic join latest funding round for startup Xealth | FierceHealthcare | 6/21/2019

… a series A financing round and has attracted new investment from major health systems Atrium Health, Cleveland Clinic and the MemorialCare Innovation Fund. The health systems join existing investors McKesson Ventures, Novartis, Philips, ResMed, Threshold … to prescribe patients digital health tools—apps, connected medical devices, digital health content and nonclinical services like food delivery—from their electronic health records (EHRs). Free Daily Newsletter Like this story? Subscribe to FierceHealthcare! The …

Atrium, Cleveland Clinic, MemorialCare join digital health startup Xealth’s Series A | Becker’s Hospital Review | 6/20/2019

MemorialCare Innovation Fund. Previously announced health system investors in the round include University of Pittsburgh Medical Center, Froedtert and the Medical College of Wisconsin network and Providence Ventures (Xealth spun out of Providence St. Joseph Health in 2017). McKesson Ventures, Novartis, Philips, ResMed and Threshold Ventures also participated. Xealth’s platform allows clinicians to prescribe and monitor digital health content, apps, devices and other services within their existing EHR system, then …

Xealth

Welldoc Data Shows Patient Engagement Increases 2.5 Times When Clinician and Xealth Involved | PR Newswire | 9/17/2019

… be four times higher when sent direct to the patient from their care team. This distribution was made possible through Xealth , the platform for connecting digital health, which integrated the BlueStar solution into the EHR … PSJH) in 2017, and investors include Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network …

How conversations with frontline hospital staff keep Xealth from becoming another ‘tone-deaf’ startup: 4 Qs with COO Aaron Sheedy | Becker’s Hospital Review | 9/10/2019

Aaron Sheedy is COO at Xealth, a Seattle-based digital health startup that makes it easier for health systems to integrate digital care vendors into their EHR platforms, from which clinicians can prescribe and monitor … year, with investors including Providence Ventures, Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, University of Pittsburgh Medical Center and Froedtert & the Medical College of Wisconsin network. In an interview with Becker’s , Mr. Sheedy described Xealth’s …

Novartis

Welldoc Data Shows Patient Engagement Increases 2.5 Times When Clinician and Xealth Involved | PR Newswire | 9/17/2019

MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network. For more information, visit www.xealth.com or follow us on LinkedIn or Twitter . SOURCE Xealth Related Links http://www.xealth.io …

Atrium Health, Cleveland Clinic join latest funding round for startup Xealth | FierceHealthcare | 6/21/2019

MemorialCare Innovation Fund. The health systems join existing investors McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network. The latest raise brings their total for the funding round to $14 million. Originally incubated and launched at Providence St. Joseph Health in 2017, Xealth is a digital prescribing platform that enables clinicians to prescribe patients digital health …

McKesson

Welldoc Data Shows Patient Engagement Increases 2.5 Times When Clinician and Xealth Involved | PR Newswire | 9/17/2019

MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network. For more information, visit www.xealth.com or follow us on LinkedIn or Twitter . SOURCE Xealth Related Links http://www.xealth.io …

Term Sheet — Monday, June 24 | Fortune | 6/24/2019

MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures, Providence Ventures, UPMC, Froedtert and the Medical College of Wisconsin health network. Advertisement PRIVATE EQUITY DEALS • L Catterton agreed to acquire Del Frisco’s Restaurant Group, Inc. (NASDAQ: DFRG) in an all cash transaction valued at approximately $650 million. • Radiant Life Care , which is backed by KKR , acquired a 49.7% stake in Max Healthcare , an India-based provider of healthcare services …

McKesson Ventures

Welldoc Data Shows Patient Engagement Increases 2.5 Times When Clinician and Xealth Involved | PR Newswire | 9/17/2019

MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network. For more information, visit www.xealth.com or follow us on LinkedIn or Twitter . SOURCE Xealth Related Links http://www.xealth.io …

Term Sheet — Monday, June 24 | Fortune | 6/24/2019

MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures, Providence Ventures, UPMC, Froedtert and the Medical College of Wisconsin health network. Advertisement PRIVATE EQUITY DEALS • L Catterton agreed to acquire Del Frisco’s Restaurant Group, Inc. (NASDAQ: DFRG) in an all cash transaction valued at approximately $650 million. • Radiant Life Care , which is backed by KKR , acquired a 49.7% stake in Max Healthcare , an India-based provider of healthcare services …

Providence Ventures

How conversations with frontline hospital staff keep Xealth from becoming another ‘tone-deaf’ startup: 4 Qs with COO Aaron Sheedy | Becker’s Hospital Review | 9/10/2019

Providence Ventures, Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, University of Pittsburgh Medical Center and Froedtert & the Medical College of Wisconsin network. In an interview with Becker’s , Mr. Sheedy described Xealth’s mission to streamline the entire care delivery process, end-to-end, by giving providers tools that will not only improve outcomes, but also lessen their own workloads. “We’re seeking out moments like that — when can we actually help doctors …

Atrium Health, Cleveland Clinic join latest funding round for startup Xealth | FierceHealthcare | 6/21/2019

MemorialCare Innovation Fund. The health systems join existing investors McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network. The latest raise brings their total for the funding round to $14 million. Originally incubated and launched at Providence St. Joseph Health in 2017, Xealth is a digital prescribing platform that enables clinicians to prescribe patients digital health …

Delphi Ventures

Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe Major Surgeries for Glaucoma Patients | PR Newswire | 5/2/2019

Delphi Ventures, Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. Media Contact Ivantis Inc. Linda Scotton [email protected] (949) 333-1323 SOURCE Ivantis, Inc. Related Links http://www.IvantisInc.com …

Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal | PR Newswire | 4/23/2019

Delphi Ventures, Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. Hydrus Microstent is not currently approved for sale in the United States for standalone use in primary open angle glaucoma. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. iStent ® and Glaukos ® are registered trademarks of Glaukos Corporation …

New Enterprise Associates

Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe Major Surgeries for Glaucoma Patients | PR Newswire | 5/2/2019

New Enterprise Associates, Delphi Ventures, Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. Media Contact Ivantis Inc. Linda Scotton [email protected] (949) 333-1323 SOURCE Ivantis, Inc. Related Links http://www.IvantisInc.com …

Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal | PR Newswire | 4/23/2019

New Enterprise Associates, Delphi Ventures, Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. Hydrus Microstent is not currently approved for sale in the United States for standalone use in primary open angle glaucoma. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. iStent ® and Glaukos ® are registered trademarks …

Ascension Ventures

Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe Major Surgeries for Glaucoma Patients | PR Newswire | 5/2/2019

Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. Media Contact Ivantis Inc. Linda Scotton [email protected] (949) 333-1323 SOURCE Ivantis, Inc. Related Links http://www.IvantisInc.com …

Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal | PR Newswire | 4/23/2019

Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. Hydrus Microstent is not currently approved for sale in the United States for standalone use in primary open angle glaucoma. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. iStent ® and Glaukos ® are registered trademarks of Glaukos Corporation. Media Contact Ivantis Inc. Linda Scotton lscotton …

Foresite Capital

Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe Major Surgeries for Glaucoma Patients | PR Newswire | 5/2/2019

Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. Media Contact Ivantis Inc. Linda Scotton [email protected] (949) 333-1323 SOURCE Ivantis, Inc. Related Links http://www.IvantisInc.com …

Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal | PR Newswire | 4/23/2019

Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. Hydrus Microstent is not currently approved for sale in the United States for standalone use in primary open angle glaucoma. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. iStent ® and Glaukos ® are registered trademarks of Glaukos Corporation. Media Contact …

RA Capital Management

Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe Major Surgeries for Glaucoma Patients | PR Newswire | 5/2/2019

RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. Media Contact Ivantis Inc. Linda Scotton [email protected] (949) 333-1323 SOURCE Ivantis, Inc. Related Links http://www.IvantisInc.com …

Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal | PR Newswire | 4/23/2019

RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. Hydrus Microstent is not currently approved for sale in the United States for standalone use in primary open angle glaucoma. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. iStent ® and Glaukos ® are registered trademarks of Glaukos Corporation. Media Contact Ivantis Inc …

Andreessen Horowitz

Term Sheet — Monday, June 24 | Fortune | 6/24/2019

… scenes even though he invested early in what are now some of the hottest companies in tech. On behalf of Andreessen Horowitz, Jordan backed home-­sharing giant Airbnb, grocery delivery company Instacart, and the hobbyist … 3 million in funding. Investors include Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures, Providence Ventures, UPMC, Froedtert and the Medical College of Wisconsin health network. Advertisement PRIVATE EQUITY …

Term Sheet – Monday, June 24 | Yahoo News | 6/24/2019

… scenes even though he invested early in what are now some of the hottest companies in tech. On behalf of Andreessen Horowitz, Jordan backed home-­sharing giant Airbnb, grocery delivery company Instacart, and the hobbyist … 3 million in funding. Investors include Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures, Providence Ventures, UPMC, Froedtert and the Medical College of Wisconsin health network. PRIVATE EQUITY DEALS …

Cleveland Clinic, Cleveland OH

How conversations with frontline hospital staff keep Xealth from becoming another ‘tone-deaf’ startup: 4 Qs with COO Aaron Sheedy | Becker’s Hospital Review | 9/10/2019

Cleveland Clinic, MemorialCare Innovation Fund, University of Pittsburgh Medical Center and Froedtert & the Medical College of Wisconsin network. In an interview with Becker’s , Mr. Sheedy described Xealth’s mission to streamline the entire care delivery process, end-to-end, by giving providers tools that will not only improve outcomes, but also lessen their own workloads. “We’re seeking out moments like that — when can we actually help doctors be better at what …

Health systems have invested millions in these 5 startups since February | Becker’s Hospital Review | 7/30/2019

Cleveland Clinic and Long Beach, Calif.-based MemorialCare Innovation Fund invested $3 million in Xealth to complete its $14 million round of Series A financing. The Seattle-based startup, a spinoff from Providence St. Joseph Health, also received funding from UPMC, Froedtert and the Medical College of Wisconsin and Providence Ventures. Xealth’s platform focuses on digital health application, allowing clinicians to prescribe and monitor digital content within the EHR system …

Cleveland Clinic

Welldoc Data Shows Patient Engagement Increases 2.5 Times When Clinician and Xealth Involved | PR Newswire | 9/17/2019

… improve health outcomes. Originally incubated and launched at Providence St. Joseph Health in 2017, Xealth works with UPMC, Atrium Health, Cleveland Clinic, Duke Health and other leading health systems. About Welldoc Welldoc® is a leading … PSJH) in 2017, and investors include Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network …

How conversations with frontline hospital staff keep Xealth from becoming another ‘tone-deaf’ startup: 4 Qs with COO Aaron Sheedy | Becker’s Hospital Review | 9/10/2019

Cleveland Clinic, MemorialCare Innovation Fund, University of Pittsburgh Medical Center and Froedtert & the Medical College of Wisconsin network. In an interview with Becker’s , Mr. Sheedy described Xealth’s mission to streamline the entire care delivery process, end-to-end, by giving providers tools that will not only improve outcomes, but also lessen their own workloads. “We’re seeking out moments like that — when can we actually help doctors be better at what …

Atrium Health

How conversations with frontline hospital staff keep Xealth from becoming another ‘tone-deaf’ startup: 4 Qs with COO Aaron Sheedy | Becker’s Hospital Review | 9/10/2019

Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, University of Pittsburgh Medical Center and Froedtert & the Medical College of Wisconsin network. In an interview with Becker’s , Mr. Sheedy described Xealth’s mission to streamline the entire care delivery process, end-to-end, by giving providers tools that will not only improve outcomes, but also lessen their own workloads. “We’re seeking out moments like that — when can we actually help doctors be better …

Health systems have invested millions in these 5 startups since February | Becker’s Hospital Review | 7/30/2019

Atrium Health, Cleveland Clinic and Long Beach, Calif.-based MemorialCare Innovation Fund invested $3 million in Xealth to complete its $14 million round of Series A financing. The Seattle-based startup, a spinoff from Providence St. Joseph Health, also received funding from UPMC, Froedtert and the Medical College of Wisconsin and Providence Ventures. Xealth’s platform focuses on digital health application, allowing clinicians to prescribe and monitor digital content within the …

UPMC

Welldoc Data Shows Patient Engagement Increases 2.5 Times When Clinician and Xealth Involved | PR Newswire | 9/17/2019

… services needed to improve health outcomes. Originally incubated and launched at Providence St. Joseph Health in 2017, Xealth works with UPMC, Atrium Health, Cleveland Clinic, Duke Health and other leading health systems. About Welldoc Welldoc … PSJH) in 2017, and investors include Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network …

Health systems have invested millions in these 5 startups since February | Becker’s Hospital Review | 7/30/2019

MemorialCare Innovation Fund invested $3 million in Xealth to complete its $14 million round of Series A financing. The Seattle-based startup, a spinoff from Providence St. Joseph Health, also received funding from UPMC, Froedtert and the Medical College of Wisconsin and Providence Ventures. Xealth’s platform focuses on digital health application, allowing clinicians to prescribe and monitor digital content within the EHR system and then share information directly with patients …

St. Joseph Health

Health systems have invested millions in these 5 startups since February | Becker’s Hospital Review | 7/30/2019

MemorialCare Innovation Fund invested $3 million in Xealth to complete its $14 million round of Series A financing. The Seattle-based startup, a spinoff from Providence St. Joseph Health, also received funding from UPMC, Froedtert and the Medical College of Wisconsin and Providence Ventures. Xealth’s platform focuses on digital health application, allowing clinicians to prescribe and monitor digital content within the EHR system and then share information directly with patients …

Atrium Health, Cleveland Clinic join latest funding round for startup Xealth | FierceHealthcare | 6/21/2019

MemorialCare Innovation Fund. The health systems join existing investors McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network. The latest raise brings their total for the funding round to $14 million. Originally incubated and launched at Providence St. Joseph Health in 2017, Xealth is a digital prescribing platform that enables clinicians to prescribe patients digital health …

Providence St. Joseph Health

How conversations with frontline hospital staff keep Xealth from becoming another ‘tone-deaf’ startup: 4 Qs with COO Aaron Sheedy | Becker’s Hospital Review | 9/10/2019

Providence St. Joseph Health in 2017. The startup closed its $14 million Series A financing round in June of this year, with investors including Providence Ventures, Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, University of Pittsburgh Medical Center and Froedtert & the Medical College of Wisconsin network. In an interview with Becker’s , Mr. Sheedy described Xealth’s mission to streamline the entire care delivery process, end-to-end, by giving providers tools …

Health systems have invested millions in these 5 startups since February | Becker’s Hospital Review | 7/30/2019

MemorialCare Innovation Fund invested $3 million in Xealth to complete its $14 million round of Series A financing. The Seattle-based startup, a spinoff from Providence St. Joseph Health, also received funding from UPMC, Froedtert and the Medical College of Wisconsin and Providence Ventures. Xealth’s platform focuses on digital health application, allowing clinicians to prescribe and monitor digital content within the EHR system and then share information directly with patients …

Mike McSherry

Atrium Health, Cleveland Clinic join latest funding round for startup Xealth | FierceHealthcare | 6/21/2019

… a series A financing round and has attracted new investment from major health systems Atrium Health, Cleveland Clinic and the MemorialCare Innovation Fund. The health systems join existing investors McKesson Ventures, Novartis, Philips, ResMed, Threshold … date, Xealth has secured $22.5 million in funding. Xealth CEO Mike McSherry said the funding will be used to further develop the platform. RELATED: CVS launching platform to allow PBM clients to manage supplemental benefit …

Providence spinout Xealth ends $14M Series A funding round | The Business Journals | 6/20/2019

MemorialCare Innovation Fund joined Xealth’s eight other investors. Xealth aims to set the bar for how doctors and clinicians interact with patients, CEO Mike McSherry said. “We digitally facilitate care in a way that’s not been provided thus far,” McSherry said. “We hope to be the benchmark of effectiveness.” Already, the company works with seven of the top 10 hospitals in the United States. It’s platform allows doctors to prescribe …